Case ReportInternational Journal of Contemporary Pediatrics

Publication:
Myelin oligodendrocyte glycoprotein antibody associated disease – two distinct clinical presentations

Int J Contemp Pediatr. 2023;10(7):1152-1154.DOI10.18203/2349-3291.ijcp20231862

Read online (HTML) View on the journal's website(opens in a new tab)

Abstract

Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is an inflammatory demyelinating disorder caused by the development of immunoglobulin G autoantibody targeting MOG, which is expressed exclusively on the outer surface of the myelin sheath and plasma membrane of oligodendrocyte. MOGAD can present in different clinical spectrum including acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), transverse myelitis and relapsing courses of these presentations. Depending on the severity, acute attacks can be treated with I V methyl prednisolone, plasma exchange or IVIG as in any demyelinating disease. This report is about 2 children with MOG antibody positive disease who presented with different symptomatology, severity and outcome.

Keywords

Affiliations

  1. Department of Paediatrics, Government Medical College, Kannur, Kerala, India
  2. Department of Neurology, Government Medical College, Kannur, Kerala, India

Full item record